CN Patent

CN115667261A — 吉泊达星的结晶形式

Assigned to GlaxoSmithKline Intellectual Property Development Ltd · Expires 2023-01-31 · 3y expired

What this patent protects

公开了吉泊达星的新结晶形式以及包含其的药物组合物。还公开了其制备方法及其使用方法。

USPTO Abstract

公开了吉泊达星的新结晶形式以及包含其的药物组合物。还公开了其制备方法及其使用方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN115667261A
Jurisdiction: CN
Classification: —
Expires: 2023-01-31
Drug substance claim: No
Drug product claim: No
Assignee: GlaxoSmithKline Intellectual Property Development Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.